Exact Mass: 275.0349
Exact Mass Matches: 275.0349
Found 55 metabolites which its exact mass value is equals to given mass value 275.0349,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
D-glucosaminic acid 6-phosphate
N-(2-formyl-3-chlorophenyl)anthranilic acid
N-(2-formyl-3-chlorophenyl)anthranilic acid belongs to the family of Aminobenzoic Acid Derivatives. These are organic compounds containing a benzoic acid moiety with an amine group attached to the benzene ring.
Lorcaserin sulfamate
Lorcaserin sulfamate is a metabolite of lorcaserin. Lorcaserin (APD-356, trade name Lorqess) is a weight-loss drug developed by Arena Pharmaceuticals. It has serotonergic properties and acts as an anorectic. On 22 December 2009 a New Drug Application (NDA) was submitted to the Food and Drug Administration (FDA) in the United States. On 16 September 2010, an FDA advisory panel voted to recommend against approval of the drug based on concerns over both safety and efficacy. (Wikipedia)
Meticrane
C - Cardiovascular system > C03 - Diuretics > C03B - Low-ceiling diuretics, excl. thiazides > C03BA - Sulfonamides, plain C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic
(5R)-3-Ethylsulfanyl-6-(1-hydroxyethyl)-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
7,8-Dihydroxy-3-(2-methyl-thiazol-4-yl)-chromen-4-one
4-(trifluoromethyl)quinoline-2-carboximidamide,hydrochloride
3-(trifluoromethyl)quinoline-2-carboximidamide,hydrochloride
7-(trifluoromethyl)quinoline-2-carboximidamide,hydrochloride
6-(trifluoromethyl)quinoline-2-carboximidamide,hydrochloride
8-(trifluoromethyl)quinoline-2-carboximidamide,hydrochloride
3-HYDROXYMETHYL-6-(2-NITROPHENYL)IMIDAZO[2,1-B]THIAZOLE
6-AMINO-5-BROMO-1-ISOBUTYL-3-METHYL-1H-PYRIMIDINE-2,4-DIONE
2-(2-CHLORO-ACETYLAMINO)-4,5-DIMETHYL-THIOPHENE-3-CARBOXYLIC ACID ETHYL ESTER
2-(5-nitrothiophen-2-yl)-2,3-dihydro-1H-quinazolin-4-one
methyl 3-(pyrrolidin-1-ylsulfonyl)thiophene-2-carboxylate
4-chloro-6-(4-methylphenyl)-2-(methylthio)pyrimidine-5-carbonitrile
4-(CHLOROMETHYL)-5-METHYL-2-(4-(TRIFLUOROMETHYL)PHENYL)OXAZOLE
(4S)-2-[3-(Difluoromethoxy)phenyl]-1,3-thiazolidine-4-carboxylic acid
3-piperidin-1-ylsulfonylthiophene-2-carboxylic acid
2-[(3-chlorophenyl)methylsulfanyl]-3H-imidazo[4,5-c]pyridine
4-Amino-N-[(2-Sulfanylethyl)carbamoyl]benzenesulfonamide
Meticrane
C - Cardiovascular system > C03 - Diuretics > C03B - Low-ceiling diuretics, excl. thiazides > C03BA - Sulfonamides, plain C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic
Lorcaserin sulfamate
Lorcaserin sulfamate is a metabolite of lorcaserin. Lorcaserin (APD-356, trade name Lorqess) is a weight-loss drug developed by Arena Pharmaceuticals. It has serotonergic properties and acts as an anorectic. On 22 December 2009 a New Drug Application (NDA) was submitted to the Food and Drug Administration (FDA) in the United States. On 16 September 2010, an FDA advisory panel voted to recommend against approval of the drug based on concerns over both safety and efficacy. (Wikipedia)
